NRSA Training

这个修订后的CTSA机构培训核心（TL 1）的目的是利用新的优势 泽西岛临床和转化科学联盟（新泽西州），伞式组织，将提供 一个基础设施，以支持和加强临床和转化研究和培训在新泽西。领导 罗格斯大学生物医学和健康科学（RBHS），由罗格斯大学翻译研究所管理 新泽西州医学与科学（RITMS）由三所大学组成的联盟（罗格斯大学， 普林斯顿大学和新泽西理工学院）和社区组织， 医院、社区卫生中心、门诊诊所、数据中心和两个卫生信息交换中心。 这种独特而充满活力的环境将使我们能够创建一个强大而有效的平台， 翻译研究者的一代。创新的翻译研究既不能教也不能完成 在一个筒仓里我们希望鼓励我们的学员考虑，从他们的博士经验的最早阶段， 他们的研究成果在疾病诊断、治疗和预防方面的应用。 为了实现这一目标，而不是将我们的培训限制在特定的部门或计划中，我们收集了 在基础生物医学和生物工程方面具有公认专业知识的高生产力导师的初始队列 研究，临床研究，生物信息学，生物统计学，机器学习，流行病学，卫生政策和其他 这些关键领域将结合起来，为我们的学员提供指导。我们的跨学科团队团结一致 作为“新泽西州导师学院”，这将是这个TL 1培训工作的教育平台。到 加强这种经验的转化性质，导师学院将由我们的新泽西州和 学员（TL 1）和学者（KL 2）。从战略上讲，我们将专注于由学生组成的培训人才库 通过选择学位和/或研究生课程，表达了对翻译基础科学的兴趣 发现和概念到疾病相关的应用（MD/PhD。PharmD/PhD，DPT/PhD，生物技术， 生物医学工程和精神病学博士）。在项目领导及其指导团队的帮助下， 每个学员将设计一个核心课程和选修课程，讲习班，研讨会和沉浸式课程 经验，以实现“精确”的培训，适合他们的需求和研究职业的愿望。我们还 我们将系统地评估我们的计划成果，使用有效和可靠的指标， 内部和外部评估小组。

This revised CTSA Institutional Training Core (TL1) has been designed to leverage the strengths of The New Jersey Alliance for Clinical and Translational Science (NJ ACTS), the umbrella organization that will provide an infrastructure to support and enhance clinical and translational research and training in New Jersey. Led by Rutgers Biomedical and Health Sciences (RBHS) and administered by the Rutgers Institute for Translational Medicine and Science (RITMS), NJ ACTS comprises an Alliance of three universities (Rutgers University, Princeton University, and the New Jersey Institute of Technology) and community-based organizations, hospitals, community health centers, outpatient practices, data centers and two Health Information Exchanges. This unique and dynamic environment will allow us to create a robust and effective platform to train the next generation of translational researchers. Innovative translational research can neither be taught nor accomplished in a silo. We want to encourage our trainees to consider, from the earliest stages of their doctoral experience, the implication and application of their research efforts to the diagnosis, treatment and prevention of disease. To accomplish this, rather than limit our training within a particular department or program, we have gathered an initial cohort of highly productive mentors with proven expertise in basic biomedical and bioengineering research, clinical research, bioinformatics, biostatistics, machine learning, epidemiology, health policy and other key areas that will coalesce to provide mentorship to our trainees. Our cross-disciplinary team has been united as the “NJ ACTS Academy of Mentors” which will be the educational platform for this TL1 training effort. To enhance the translational nature of this experience, the Academy of Mentors will be shared by both our NJ ACTS Trainees (TL1) and Scholars (KL2). Strategically, we will focus on a trainee pool composed of students who have expressed, by choice of degree(s) and/or graduate program, an interest in translating basic science findings and concepts into disease-relevant applications (MD/PhD. PharmD/PhD, DPT/PhD, Biotechnology, Biomedical Engineering and Psychiatry PhD). With the help of the program leadership and their mentoring team, each trainee will design a curriculum of core and elective courses, workshops, seminars and immersion experiences, to achieve “precision” training tailored to their needs and research career aspirations. Further, we will systematically assess our programmatic outcomes using valid and reliable metrics within the context of an internal and external evaluation team.